Patricia Romano-Martin

University of Paris-Saclay - Gustave Roussy Cancer Center

France

SCHOLARLY PAPERS

2

DOWNLOADS

102

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Neurological Complications Induced by Anti-PD-1 or Anti-PD-L1: Prevalence, Clinical Description and Treatment: 5-Years Experience of a National Network

Number of pages: 36 Posted: 23 Dec 2019
Bicêtre University Hospital - Neurology Department, Gustave Roussy - Drug Development Department (DITEP), Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Bicêtre University Hospital - Neurology Department, Bicêtre University Hospital - Neurology Department, Bicêtre University Hospital - Neurology Department, Bicêtre University Hospital - Neurology Department, Hôpital Saint-Eloi, University of Nantes, University of Nantes, University of Compiegne, Bicêtre University Hospital - Neurology Department, Bicêtre University Hospital - Neurology Department, Bicêtre University Hospital - Neurology Department, Hôpitaux Universitaires Paris-Sud-Hôpital Bicêtre, Bicêtre University Hospital - Assistance Publique-Hôpitaux de Paris and Bicêtre University Hospital - Neurology Department
Downloads 53 (686,824)

Abstract:

Loading...

immune related adverse events; immunotherapy; neurological complications

2.

The 2016-2019 ImmunoTOX Assessment Board Report: Results from a Descriptive Real-Life Study of a Collaborative Management of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors

Number of pages: 43 Posted: 03 Oct 2019
Gustave Roussy - Drug Development Department (DITEP), Universite Paris Descartes - Assistance Publique - Hôpitaux de Paris, Hôpital Marie-Lannelongue, University of Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Assistance Publique-Hôpitaux de Paris - Hepato-Biliary Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Assistance Publique-Hôpitaux de Paris, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, University of Paris-Saclay, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpital de Bicêtre, Peupliers Private Hospital, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, Hôpital Bicêtre, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, University of Paris-Saclay - Gustave Roussy Cancer Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus and Hôpitaux Universitaires Paris-Sud-Hôpital Bicêtre
Downloads 49 (711,164)

Abstract:

Loading...

Patient care network; Multidisciplinary collaborative approach; Immune-related adverse event; Immune checkpoint inhibitor